Task: Answer the MCQ question.
Query: Which drug exhibits a 11.809\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: Cl.O=C(CN1CCCC1)Nc1cccc(Cl)c1
b: COC(=O)N[C@H](CC(C)=O)c1ccccc1
c: Cn1ncc(Br)c1NC(=O)CSc1ccc(Cl)cc1
Answer: c. Cn1ncc(Br)c1NC(=O)CSc1ccc(Cl)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1ncc(Br)c1NC(=O)CSc1ccc(Cl)cc1
Cn1ncc(Br)c1NC(=O)CSc1ccc(Cl)cc1
N-(4-bromo-2-methylpyrazol-3-yl)-2-(4-chlorophenyl)sulfanylacetamide